Show simple item record

dc.contributor.authorVojkovics, Dóra
dc.contributor.authorKellermayer, Zoltán
dc.contributor.authorKajtár, Béla
dc.contributor.authorRoncador, Giovanna 
dc.contributor.authorVincze, Áron
dc.contributor.authorBalogh, Péter
dc.date.accessioned2019-09-26T10:19:52Z
dc.date.available2019-09-26T10:19:52Z
dc.date.issued2018-02-06
dc.identifier.citationBiomark Insights. 2018;13:1177271918757480es_ES
dc.identifier.issn1177-2719es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8383
dc.description.abstractThe development of peripheral lymphoid tissues from the mesoderm is the result of a complex convergence combining lymphohematopoietic differentiation with the local specification of nonhematopoietic mesenchymal components. Although the various transcriptional regulators with fate-determining effects in diversifying the mobile leukocyte subsets have been thoroughly studied and identified, the tissue-specific determinants promoting the regional differentiation of resident mesenchyme are less understood. Of these factors, various members of the NK-class Nkx paralogues have emerged as key regulators for the organogenesis of spleen and mucosal lymphoid tissues, and recent data have also indicated their involvement in various pathological events, including gut inflammation and hematopoietic malignancies. Here, we summarize available data on the roles of Nkx2-3 in lymphoid tissue development and discuss its possible value as a developmental marker and disease-associated pathogenic trait.es_ES
dc.description.sponsorshipThe author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Z.K. is supported by the ÚNKP-17-4-I New National Excellence Program of the Ministry of Human Capacities and the postdoctoral research grant of the Faculty of Medicine, University of Pécs. This work was supported by OTKA K108429, GINOP-232-15-2016-00050, and EFOP-361-16-2016- 00004 research funds.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Media es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectNkx2-3es_ES
dc.subjectinflammationes_ES
dc.subjectlymphoid organses_ES
dc.subjectlymphomaes_ES
dc.titleNkx2-3-A Slippery Slope From Development Through Inflammation Toward Hematopoietic Malignancieses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID29449776es_ES
dc.format.volume13es_ES
dc.format.page1177271918757480es_ES
dc.identifier.doi10.1177/1177271918757480es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1177/1177271918757480.es_ES
dc.identifier.journalBiomarker insightses_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Anticuerpos Monoclonaleses_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FFI2016-78034-C2-2-Pes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional